- Home
- FATE vs NMT Comparison
FATE vs NMT Comparison
Compare FATE & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- NMT
- Stock Information
- Founded
- FATE 2007
- NMT 1993
- Country
- FATE United States
- NMT United States
- Employees
- FATE N/A
- NMT N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- NMT Finance/Investors Services
- Sector
- FATE Health Care
- NMT Finance
- Exchange
- FATE Nasdaq
- NMT Nasdaq
- Market Cap
- FATE 108.2M
- NMT 110.6M
- IPO Year
- FATE 2013
- NMT N/A
- Fundamental
- Price
- FATE $0.77
- NMT $11.89
- Analyst Decision
- FATE Hold
- NMT
- Analyst Count
- FATE 9
- NMT 0
- Target Price
- FATE $5.50
- NMT N/A
- AVG Volume (30 Days)
- FATE 1.6M
- NMT 19.1K
- Earning Date
- FATE 03-05-2025
- NMT 01-01-0001
- Dividend Yield
- FATE N/A
- NMT 3.21%
- EPS Growth
- FATE N/A
- NMT N/A
- EPS
- FATE N/A
- NMT N/A
- Revenue
- FATE $13,631,000.00
- NMT N/A
- Revenue This Year
- FATE N/A
- NMT N/A
- Revenue Next Year
- FATE N/A
- NMT N/A
- P/E Ratio
- FATE N/A
- NMT N/A
- Revenue Growth
- FATE N/A
- NMT N/A
- 52 Week Low
- FATE $0.74
- NMT $9.05
- 52 Week High
- FATE $7.35
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- FATE 33.08
- NMT 61.57
- Support Level
- FATE $0.83
- NMT $11.72
- Resistance Level
- FATE $0.96
- NMT $11.78
- Average True Range (ATR)
- FATE 0.06
- NMT 0.09
- MACD
- FATE -0.00
- NMT 0.01
- Stochastic Oscillator
- FATE 11.54
- NMT 74.87
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes by investing in a portfolio of municipal obligations issued by state and local government authorities within a single state or certain U.S. territories.